Investing.com - Fresenius Medical Care (NYSE:FMS) ADR reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Fresenius Medical Care ADR announced earnings per share of $0.68 on revenue of $4.55. Analysts polled by Investing.com anticipated EPS of $0.3564 on revenue of $4.86B.
Fresenius Medical Care ADR shares are down 6.69% from the beginning of the year, still down 28.65% from its 52 week high of $42.45 set on June 16, 2021. They are under-performing the EUR/USD which is down 0% from the start of the year.
Fresenius Medical Care ADR shares lost 4.27% in intra-day trade following the report.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by J&J on April 19, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on April 14 with first quarter EPS of $5.49 on revenue of $80.15B, compared to forecast for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar